For instance, in cervical cancer, the integration of HPV in the CCDC106 gene resulted in its overexpression and subsequent tumour progression by interacting with tumour suppressor p53 and causing p53 degradation, suggesting its use as a potential therapeutic target.61, 62, 63. This evidence concerns the gene TP53 and neoplasm.